Differences

This shows you the differences between two versions of the page.

--- en:start [2025/05/23 11:22]
Gianluca Frustagli
+++ en:start [2025/08/24 15:38] (current)
Gianluca Frustagli "Project GENEVAX": fixed link to logos.
@@ Line 12: / Line 12: @@
 The **[[https://www.iss.it|ISS]] - Core Facilities Technical-Scientific Service** is a centralized shared resource that provides access to instruments and technologies, as well as expert consultation, to scientific researchers.
-{{map> :esagoni-eng.png?380|Core facilities}}
+{{map> :esagoni-eng.png?300|Core facilities}}
 /* "Logo" ad esagoni con mappa dei link. Le coordinate sono scalate sull'immagine ridimensionata, riscalando l'immagine occorre (purtroppo) riscalare a mano anche le coordinate. */
-  * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 166,3,208,3,230,40,208,77,166,78,144,41]]
+  * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 124,100,175,100,201,144,176,189,125,189,99,145]]
-  * [[en:aree:ngs:start|Area Sequenziamento @ 308,84,351,84,372,121,351,158,308,158,287,122]]
+  * [[en:aree:ngs:start|Area Sequenziamento @ 209,53,260,52,286,97,261,141,209,141,185,97]]
-  * [[en:aree:fabiocell:start|Area FaBioCell @ 237,42,279,42,301,79,280,117,237,118,215,80]]
+  * [[en:aree:citometria:start|Area Citometria @ 210,149,261,149,286,193,261,238,210,238,185,193]]
-  * [[en:aree:citometria:start|Area Citometria @ 237,126,280,125,301,162,280,199,237,200,216,162]]
+  * [[en:aree:epr:start|Area EPR @ 125,197,176,197,201,241,176,286,125,285,100,242]]
-  * [[en:aree:epr:start|Area EPR @ 165,166,208,166,230,203,208,240,166,239,144,203]]
+  * [[en:aree:nmr:start|Area NMR @ 39,149,89,149,115,193,90,237,39,237,14,193]]
-  * [[en:aree:nmr:start|Area NMR @ 93,125,136,125,157,162,136,199,93,199,72,163]]
+  * [[en:aree:microscopia:start|Area Microscopia @ 98,48,124,3,174,3,200,47,174,92,124,91]]
-  * [[en:aree:microscopia:start|Area Microscopia @ 23,84,66,84,88,120,66,158,23,159,1,121]]
+  * [[en:aree:proteomica:start|Area Proteomica @ 39,51,90,51,116,94,91,139,39,139,14,95]]
-  * [[en:aree:proteomica:start|Area Proteomica @ 93,42,136,42,158,79,136,117,94,117,72,80]]
-  * [[en:aree:start|Aree @ 166,84,211,84,234,123,211,160,166,160,145,122]]
 {{<map}}
@@ Line 47: / Line 45: @@
 > ☎ **+39 06 4990 3313**
-/* > FIXME **To be revised by A.**\\ //(remove this paragraph once the translation is finished)// */
 ----
@@ Line 55: / Line 52: @@
 NICo’s goal is to foster **positive synergies** among Core Facilities operating in the field of **Life Sciences** and to enhance their **visibility and accessibility**.
 \\
@@ Line 239: / Line 237: @@
 <wrap bigger>**GENEVAX Project**</wrap>
-{{ :aree:fabiocell:genevax-loghi.png?350 |}}
+{{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}}
-In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]]
+In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]]
@@ Line 594: / Line 592: @@
 <wrap bigger>**GENEVAX Project**</wrap>
-{{ :aree:fabiocell:genevax-loghi.png?350 |}}
+{{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}}
-In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]]
+In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]]
@@ Line 705: / Line 703: @@
 </ifinternet> /* END OF INTERNET VERSION "NEWS" */